Pazopanib for renal cell carcinoma leads to elevated mean arterial pressures in a murine model
Background: In the setting of metastatic RCC (mRCC), pazopanib is approved as first line therapy. Unfortunately treatment may lead to cardiotoxicity such as hypertension, heart failure, and myocardial ischemia. Objective: Define the in vivo role of pazopanib in the development of cardiotoxicity. Met...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2018-08-01
|
| Col·lecció: | Clinical and Experimental Hypertension |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/10641963.2017.1403623 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|